Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingDevelopment of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia.Risk of second cancers in survivors of prolymphocytic leukemia: a SEER data analysis.Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial.Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtypeIncreased risk of second primary cancers after a diagnosis of melanomaIncreased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphomaSecond cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphomaThe Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia.Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.Synchronous breast carcinoma and chronic lymphocytic leukemia in a Chinese young female: a rare combination.Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in MinnesotaSurvival analysis in hematologic malignancies: recommendations for cliniciansRisk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanomaManagement of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.Melanoma in immunosuppressed patientsFludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia.Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaSecondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population-based study.Increased risk of second malignancies in chronic lymphocytic leukaemia patients as compared with follicular lymphoma patients: a Canadian population-based studyGenetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.A systematic review on Richter syndrome: what is the published evidence?Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.Lymphoma-associated skin cancer: incidence, natural history, and clinical management.Aggressive behavior of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.Shifting paradigms in the treatment of chronic lymphocytic leukemia.A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.Differential diagnosis problems in a patient with dysphonia and chronic lymphocytic leukemiaIncidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients.Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients.
P2860
Q23923997-AB6FEF7A-AEB0-4E3A-A619-4716EA6AB79BQ30238679-936EF3F8-D896-4D15-8E89-1448CF1AFF23Q31147302-75C2340E-0271-47F3-B1A4-3C99D66E7E1FQ33386533-40FFAD6B-1A90-4485-AEAA-6AAC4D333EFDQ33421376-70C788F0-2575-4F69-AC1B-476DDF2ED97EQ33429161-9BA47ABB-3CFB-4278-A466-5C656DD972C5Q34488720-9F23456C-3713-48AE-8ED0-0AA2F179E6CCQ34793496-1ACA2C2C-805B-46B5-97B2-CB4F73003B77Q35136073-001B3B1F-D368-4D34-8AB7-5EC160AFEB03Q35262838-545E1D67-F8ED-4517-842C-05484F4ED609Q35569501-D9094842-0AFF-4CD4-9ABF-3CEF3D5CF2C4Q35583403-0C11F9BC-C839-4D56-AB05-8D4844205B6FQ35625192-BDADD1A2-F9FE-45E9-B77C-F995B842F338Q35854470-AB405F0E-AF28-4A14-AF39-9C673AA864F0Q35867744-20F74B28-4625-4EA1-B227-778B967FC5E3Q36036279-7F5BB71E-FBAF-4810-B678-7851E97B5904Q36090959-4D7DAFE6-851A-47B4-B06B-6C0A204011B5Q36163620-E5A0A5AC-1056-4384-8ED4-5E88CAD32DF9Q36251887-DCF5A484-F74B-41C0-8835-25CC7454345FQ36512842-9028FD47-2EC3-4E66-BDC8-2506B9968282Q36597026-FDF89F19-FE42-401F-A63C-8CAA8F0D4670Q36806417-BD17A4AA-269B-4817-BC8B-44CCC665D550Q36822986-21F7AACB-2EB8-4039-B1AC-F7E04876BF76Q36929831-7CF20BED-D0EF-4393-9EE3-65A3EEBE4AB2Q36935200-A7F35D12-0B81-4945-ABA9-E76410138710Q36974374-3ACA6553-08C0-4378-AC16-AC4798CC231CQ37045487-48F46B43-E485-4D9B-AE45-ED4DC6CE0A03Q37185719-3A9A3A41-F7F0-4050-BC50-E0153E0FB3DAQ37406801-52298D29-51BC-4B89-B174-20894A0362B9Q37676244-C85F13A1-3C1A-4D84-9324-57BD03F5F113Q37854256-AB8B228E-D54B-4404-9649-4D5168E7A3FBQ37879960-0D6B105C-150F-4230-BE02-A930BF999A3DQ38169774-2E4252C1-E9CD-4E33-8F97-AC4A16A7753AQ38176823-897B26EB-1351-4D4E-86B7-C8BF17CBE0B7Q38357127-CA683330-0776-4495-A4BF-9FD9D6501D9EQ38664705-51015A01-9635-4E5A-A259-CACDE3D579F3Q39227230-5307FBF6-31BB-4B1B-AF25-40BAA432F118Q39260356-2969432C-B9B2-412C-BE29-5B8F3E74235BQ39354550-2BFB683B-D3D1-41B7-858F-AB1FFBE3508FQ40134377-5AE43A26-6454-4F92-A5C3-4099F12C51CF
P2860
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
@en
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
@nl
type
label
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
@en
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
@nl
prefLabel
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
@en
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
@nl
P2093
P2860
P50
P356
P1476
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
@en
P2093
Emil J Freireich
L Jeffrey Medeiros
Peter McLaughlin
Sara Strom
P2860
P304
P356
10.1200/JCO.2008.17.5398
P407
P50
P577
2008-12-29T00:00:00Z